JAMA Network
About The Study: Among people with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation, treatment with the β1-selective β-blocker bisoprolol did not reduce the number of self-reported COPD exacerbations requiring treatment with oral corticosteroids, antibiotics, or both.
Quote from corresponding author Graham Devereux, M.D.:
"People with COPD are at increased risk of cardiovascular conditions that benefit from treatment with beta-blockers. However, there is a well-documented reluctance for physicians to prescribe beta-blockers for people with cardiovascular disease and COPD.
"These findings will help physicians and patients with COPD assess the risks and benefits of using bisoprolol to treat cardiovascular disease."
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3Lm1pcmFnZW5ld3MuY29tL2hpZ2gtcmlzay1jb3BkLXBhdGllbnRzLWJlbmVmaXQtZnJvbS1iaXNvcHJvbG9sLTEyMzgwMzcv0gEA?oc=5
2024-05-19 13:04:00Z
CBMiU2h0dHBzOi8vd3d3Lm1pcmFnZW5ld3MuY29tL2hpZ2gtcmlzay1jb3BkLXBhdGllbnRzLWJlbmVmaXQtZnJvbS1iaXNvcHJvbG9sLTEyMzgwMzcv0gEA
Bagikan Berita Ini
0 Response to "High-Risk COPD Patients Benefit from Bisoprolol Treatment - Mirage News"
Post a Comment